MyAverix Finance
F · Healthcare
LIVZON PHARMAC. GRP H YC1 (LP6)
Drug Manufacturers - Specialty & Generic
LIVZON PHARMAC. GRP H YC1 (LP6) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $2.56B, P/E ratio is 10.29, net margin is 16.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LP6
LIVZON PHARMAC. GRP H YC1 (LP6) — FAQ
What is LIVZON PHARMAC. GRP H YC1's market cap?
LIVZON PHARMAC. GRP H YC1 (LP6) has a reported market cap of $2.56B (data as of 2026-03-30).
What is LP6's P/E ratio?
The price-to-earnings (P/E) ratio for LIVZON PHARMAC. GRP H YC1 (LP6) is 10.29 (data as of 2026-03-30).
Does LIVZON PHARMAC. GRP H YC1 pay a dividend?
Dividend yield is not available in the current snapshot for LIVZON PHARMAC. GRP H YC1 (LP6). Check the MyAverix Finance app for the latest dividend data.
What sector is LIVZON PHARMAC. GRP H YC1 in?
LIVZON PHARMAC. GRP H YC1 (LP6) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LP6 listed on?
LP6 is listed on F.
What is LIVZON PHARMAC. GRP H YC1's net margin?
LIVZON PHARMAC. GRP H YC1 (LP6) reports a net margin of 16.8% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.